Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Chinese herbal recall

This article was originally published in The Tan Sheet

Executive Summary

New York City-based Kingsway Trading Inc. is voluntarily recalling two of its Chinese herbal supplements because they contain aristolochic acid; the ingredient was found in Kingsway Trading's Expellin Extract and Cardioflex. Aristolochic acid has been linked to an increased risk of kidney cancer and in some cases kidney failure (1"The Tan Sheet" April 16, 2001, p. 9). An FDA district office in New York collected samples during a routine inspection and subsequent testing revealed the presence of the ingredient. The company issued a recall letter to customers Nov. 12...

You may also be interested in...



Aristolochia Renal Disease Link Reported In Two U.S. Cases

Aristolochic acid-containing botanicals were used by two individuals in the U.S. who developed end-stage renal disease, FDA reports in an April 4 letter urging health professionals to more closely monitor their patients' dietary supplement intake.

Fujifilm Demonstrates Health Specialism With European HealthTech Spinout

From X-ray film in 1936 to the world’s first digital X-ray system in 1983, Fujifilm has a long heritage in medical diagnostics. 

Financing Quarterly Statistics, Q1 2024

During Q1, biopharmas brought in an aggregate $30.1bn in financing and device company fundraising totaled $2.8bn; while in vitro diagnostic firms and research tools players raised $724m.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS097511

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel